Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Work In Process (2019 - 2025)

Historic Work In Process for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $577000.0.

  • Pulmonx's Work In Process rose 5636.86% to $577000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $577000.0, marking a year-over-year increase of 5636.86%. This contributed to the annual value of $457000.0 for FY2024, which is 702.58% up from last year.
  • Latest data reveals that Pulmonx reported Work In Process of $577000.0 as of Q3 2025, which was up 5636.86% from $562000.0 recorded in Q2 2025.
  • Pulmonx's 5-year Work In Process high stood at $784000.0 for Q2 2022, and its period low was $313000.0 during Q1 2021.
  • For the 5-year period, Pulmonx's Work In Process averaged around $513842.1, with its median value being $503000.0 (2025).
  • As far as peak fluctuations go, Pulmonx's Work In Process skyrocketed by 13961.66% in 2022, and later plummeted by 3915.09% in 2024.
  • Quarter analysis of 5 years shows Pulmonx's Work In Process stood at $518000.0 in 2021, then decreased by 25.48% to $386000.0 in 2022, then increased by 10.62% to $427000.0 in 2023, then rose by 7.03% to $457000.0 in 2024, then increased by 26.26% to $577000.0 in 2025.
  • Its Work In Process stands at $577000.0 for Q3 2025, versus $562000.0 for Q2 2025 and $503000.0 for Q1 2025.